March 9, 2017
Treatment Action Group (TAG) is conducting a survey of community perspectives on provision of Truvada for PrEP in clinical trials of biomedical HIV prevention interventions. We would be very grateful if you would consider completing the survey, which will be anonymous and is online at: http://www.treatmentactiongroup.org/content/community-survey-prep-and-biomedical-prevention-clinical-trials. Deadline: Monday, 20 March 2017, 5:00PM EST.